HIGHLIGHTS
- who: Enrico Maria Pasqual and collaborators from the Advanced Center, ASUFC, DAME, University of Udine, Udine, Italy have published the research: Repeated Cytoreduction Combined with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Selected Patients Affected by Peritoneal Metastases: Italian PSM Oncoteam Evidence, in the Journal: (JOURNAL)
- what: This study evaluates the safety efficacy and associated factors of iterative CRS combined with HIPEC.
- how: A further limitation of the retrospective studies is the immortality bias in this study the survival curves were also evaluated starting from the date of the procedure to minimize the effect of . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.